Skip to Content

Featured UW Cancer Publications

1. Jarrard DF, Blute ML, Ritter MA. Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer. J. Clin. Oncol. 2014 Dec 10; 32(35):3926-9.
[PubMed ID: 25332250]
More Information
2. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol 2014 Oct; 11(10):589-96.
[PubMed ID: 25245244]
More Information
3. Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur. Urol. 2014 Dec; 66(6):1139-47.
[PubMed ID: 25194909]
More Information
4. Richards KA, Negron E, Cohn JA, Steinberg Z, Eggener SE, Shalhav AL. The impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy. J. Endourol. 2014 Nov; 28(11):1338-44.
[PubMed ID: 24935823, PMCID: 4382827]
More Information
5. Large MC, Malik R, Cohn JA, Richards KA, Ganshert C, Kunnavakkum R, Smith ND, Steinberg GD. Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion. Urology 2014 Oct; 84(4):808-13.
[PubMed ID: 25109565]
More Information
6. Cohen A, Richards KA, Patel S, Weiner A, Eggener SE, Szmulewitz RZ. Metastatic small cell carcinoma of the prostate: Population-based analysis of patient characteristics and treatment paradigms. Urol. Oncol. 2015 Feb; 33(2):70.e1-7.
[PubMed ID: 25044254]
More Information
7. Cowan NG, Chen Y, Downs TM, Bochner BH, Apolo AB, Porter MP, La Rochelle JC, Amling CL, Koppie TM. Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions. Adv Urol 2014; 2014():746298.
[PubMed ID: 24982672, PMCID: 4058463]
More Information
8. Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, Heckman JE, Merril MM, Gayed BA, Sagalowsky AI, Boorjian SA, Margulis V, Leibovich BC. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J. Urol. 2014 Oct; 192(4):1050-6.
[PubMed ID: 24704115]
More Information
9. Abel EJ, Wong K, Sado M, Leverson GE, Patel SR, Downs TM, Jarrard DF. Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS 2014 Apr-Jun; 18(2):282-7.
[PubMed ID: 24960494, PMCID: 4035641]
More Information
10. Damaschke NA, Yang B, Bhusari S, Svaren JP, Jarrard DF. Epigenetic susceptibility factors for prostate cancer with aging. Prostate 2013 Dec; 73(16):1721-30.
[PubMed ID: 23999928, PMCID: 4237278]
More Information
11. Yang B, Bhusari S, Kueck J, Weeratunga P, Wagner J, Leverson G, Huang W, Jarrard DF. Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. Neoplasia 2013 Apr; 15(4):399-408.
[PubMed ID: 23555185, PMCID: 3612912]
More Information
12. Slezak J, Truong M, Huang W, Jarrard D. HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy. BMC Cancer 2013 Mar 23; 13():148.
[PubMed ID: 23522301, PMCID: 3618256]
More Information
13. Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin. Prostate 2013 Jun; 73(9):970-8.
[PubMed ID: 23335089, PMCID: 3755376]
More Information
14. Truong M, Yang B, Jarrard DF. Toward the detection of prostate cancer in urine: a critical analysis. J. Urol. 2013 Feb; 189(2):422-9.
[PubMed ID: 23017522, PMCID: 3581046]
More Information

Our urologic oncologists are prolific journal authors. To view full lists of their articles, visit their profile pages:

E. Jason Abel, MD, FACS

Tracy M. Downs, MD, FACS

David F. Jarrard, MD

Kyle A. Richards, MD Copyright © 2018 The Board of Regents of the University of Wisconsin System